Appointment booking for Dr. Thomas Anderson, DO is currently not available.Dr. Thomas Anderson, DO has not yet fully activated their profile on DiabetesIQ.
Dr. Thomas Anderson, DO (he/him) is a Radiologist in Columbus, OH with over 18 years of experience. What is your opinion of Dr. Thomas Anderson, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Thomas Anderson, DO has received over $1,646 which includes payments from the following companies:
$350.83 from Merck Sharp & Dohme Corporation
$349.11 from Genentech USA, Inc.
$176.07 from Astellas Pharma US Inc
$134.99 from Eisai Inc.
$123.14 from Pfizer Inc.
$99.48 from Bayer HealthCare Pharmaceuticals Inc.
$92.11 from INSYS Therapeutics Inc
$81.02 from Puma Biotechnology, Inc.
$65.33 from Amarin Pharma Inc.
$34.48 from AstraZeneca Pharmaceuticals LP
$26.76 from Augmenix, Inc.
$26.07 from Lexicon Pharmaceuticals, Inc.
$21.06 from Amgen Inc.
$16.87 from E.R. Squibb & Sons, L.L.C.
$13.51 from Siemens Medical Solutions USA, Inc.
$12.95 from Cumberland Pharmaceuticals, Inc.
$12.03 from Boston Scientific Corporation
$10.77 from Emergent Biosolutions Inc.
Payments received by Dr. Thomas Anderson, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!